Relmada Therapeutics Inc (RLMD)

HEALTH CARE: PHARMACEUTICALS
SIC: PHARMACEUTICAL PREPARATIONS

880 3RD AVENUE, 12TH FLOOR NEW YORK, NY 10022

Relmada Therapeutics is a late-stage biotechnology company addressing diseases of the central nervous system (CNS), with a focus on major depressive disorder (MDD). Its experienced and dedicated team is committed to making a difference in the lives of patients and their families. Relmada' s lead program, REL-1017, is a novel NMDA receptor (NMDAR) channel blocker that preferentially targets hyperactive channels while maintaining physiological glutamatergic neurotransmission. REL-1017 has entered late-stage development as an adjunctive treatment for MDD in adults.

Data as of 2021-08-02 08:32:58 -0400
Market Cap435.43 Million Shares Outstanding16.747 Million Avg 30-day Volume361.96 Thousand
P/E Ratio Dividend Yield EPS
Price/Sales Debt to Equity EBITDA
Price to Book Value0.0 Forward PE-4.4 Enterprise Value
Total Cash Current Debt Gross Profit
BETA0.71661 52-week High/Low40.87 / 23.28 Next Earnings Date2021-08-11 Price to Cash FLow (P/CF) -24.13
Data provided by IEX Cloud
View SEC Filings from RLMD instead.
Q1 2021 All 13F Filers Prior Change Hedge Funds 1 Prior Change
In top 10: 2 2 0.0% 0 (0.0%) 1 (0.06%) -100.0%
Funds Holding: 82 80 2.5% 22 (1.29%) 22 (1.28%) 0.0%
13F shares: 9.532 Million 9.311 Million 2.37% 5.086 Million 4.783 Million 6.33%
% Ownership 56.9191 57.3287 -0.71% 30.3691 29.449 3.12%
New Positions: 12 13 -7.69% 5 5 0.0%
Increased Positions 19 26 -26.92% 5 8 -37.5%
Closed Positions 10 5 100.0% 5 3 66.67%
Reduced Positions 27 24 12.5% 7 5 40.0%
Total Calls 454.485 Thousand 207.343 Thousand 119.19% 342.029 Thousand 99.5 Thousand 243.75%
Total Puts 30.621 Thousand 2.301 Thousand 1230.77% 13.2 Thousand
PUT/CALL Ratio 0.07 0.01 600.0% 0.04 0.0
1 hedge funds and active managers as identified by whalewisdom.com through public filings.

View recent insider trading info

Funds Holding RLMD (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding RLMD BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

3.3 Thousand total shares from 2 transactions

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

CASAMENTO CHARLES J

  • Director
10,554 2021-07-15 13

TRAVERSA SERGIO CEO

  • Officer
  • Director
472,453 2021-03-09 10

KELLY PAUL EDWARD

  • Director
217,795 2021-03-09 10

SHENOUDA MAGED CFO

  • Officer
84,706 2021-03-08 9

ENCE CHUCK CHIEF COMPLIANCE OFFICER

  • Officer
0 2021-01-07 1

SCHMIDT ERIC THOMAS

  • Director
0 2021-01-07 1

GLASSPOOL JOHN

  • Director
0 2021-01-07 1

WESSEL THOMAS EVP, HEAD OF R&D

  • Officer
0 2020-03-09 0

VITOLO OTTAVIO V. CMO

  • Officer
0 2019-12-19 0

AGHARKAR SHREERAM

  • Director
5,759 2015-12-31 0

SETH SANDESH

  • Director
123,258 2015-12-15 0

NOLAN LISA CHIEF BUSINESS OFFICER

  • Officer
10,000 2015-12-14 0

BECK DOUGLAS CHIEF FINANCIAL OFFICER

  • Officer
0 2015-02-23 0

SALINAS ELISEO ORESTE PRESIDENT AND CSO

  • Officer
0 2015-02-23 0

YAZGI NABIL

  • Director
185,000 2015-01-06 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

CASAMENTO CHARLES J - Director

2021-07-16 17:00:23 -0400 2021-07-15 S 2,136 $31.03 d 5,854 direct yes -0.8539 -17.5041 0.0 1 -17.5041 6

CASAMENTO CHARLES J - Director

2021-07-16 17:00:23 -0400 2021-07-15 S 1,164 $32.49 d 4,700 direct yes -0.8539 -17.5041 0.0 1 -17.5041 6

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available
RELMADA THERAPEUTICS INC RLMD 2021-08-05 22:15:04 UTC -0.5786 0.6586 100000
RELMADA THERAPEUTICS INC RLMD 2021-08-05 21:45:03 UTC -0.5786 0.6586 100000
RELMADA THERAPEUTICS INC RLMD 2021-08-05 21:15:03 UTC -0.5786 0.6586 100000
RELMADA THERAPEUTICS INC RLMD 2021-08-05 20:45:03 UTC -0.5786 0.6586 100000
RELMADA THERAPEUTICS INC RLMD 2021-08-05 20:15:04 UTC -0.5786 0.6586 100000
RELMADA THERAPEUTICS INC RLMD 2021-08-05 19:45:04 UTC -0.5786 0.6586 100000
RELMADA THERAPEUTICS INC RLMD 2021-08-05 19:15:03 UTC -0.5786 0.6586 100000
RELMADA THERAPEUTICS INC RLMD 2021-08-05 18:45:03 UTC -0.5786 0.6586 100000
RELMADA THERAPEUTICS INC RLMD 2021-08-05 18:15:03 UTC -0.5786 0.6586 100000
RELMADA THERAPEUTICS INC RLMD 2021-08-05 17:45:03 UTC -0.5786 0.6586 100000
RELMADA THERAPEUTICS INC RLMD 2021-08-05 17:15:03 UTC -0.5786 0.6586 100000
RELMADA THERAPEUTICS INC RLMD 2021-08-05 16:45:02 UTC -0.5786 0.6586 100000
RELMADA THERAPEUTICS INC RLMD 2021-08-05 16:15:03 UTC -0.5786 0.6586 100000
RELMADA THERAPEUTICS INC RLMD 2021-08-05 15:45:03 UTC -0.5786 0.6586 100000
RELMADA THERAPEUTICS INC RLMD 2021-08-05 15:15:02 UTC -0.5786 0.6586 100000
RELMADA THERAPEUTICS INC RLMD 2021-08-05 14:45:02 UTC -0.5786 0.6586 100000
RELMADA THERAPEUTICS INC RLMD 2021-08-05 14:15:04 UTC -0.5786 0.6586 100000
RELMADA THERAPEUTICS INC RLMD 2021-08-05 13:45:04 UTC -0.5786 0.6586 100000
RELMADA THERAPEUTICS INC RLMD 2021-08-05 13:15:03 UTC -0.5786 0.6586 100000
RELMADA THERAPEUTICS INC RLMD 2021-08-05 12:45:03 UTC -0.5786 0.6586 100000

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin
ADVISORS' INNER CIRCLE FUND II- Hancock Horizon Quantitative Long/Short Fund RLMD -11250.0 shares, $-396112.5 2021-03-31 N-PORT
Columbia Funds Series Trust I- Multi-Manager Directional Alternative Strategies Fund RLMD -2602.0 shares, $-100333.12 2021-04-30 N-PORT
INVESTMENT MANAGERS SERIES TRUST- 361 Global Long/Short Equity Fund RLMD -16263.0 shares, $-627101.28 2021-04-30 N-PORT
PACE SELECT ADVISORS TRUST- PACE Alternative Strategies Investments RLMD -2277.0 shares, $-87801.12 2021-04-30 N-PORT

Elevate your investments